Jin Biotech Reports Over 1000% Increase in Net Loss
[Asia Economy Reporter Ji Yeon-jin] Jin Biotech announced on the 3rd that its sales revenue last year reached 62.3 billion KRW, an increase of 7.03% compared to the previous year. Operating profit decreased by 88.81% to approximately 900 million KRW, and net loss for the period expanded by 1031% to 300 million KRW.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
The company decided to pay a cash dividend of 30 KRW per common share.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.